Divis Laboratories has informed that a meeting of Board of Directors of the Company will be held on February 05, 2016, to consider and approve the un-audited financial results for the quarter and nine months ended December 31, 2015 (Q3). Further, the Trading Window for dealing in securities of the Company shall remain closed for insiders of the Company from January 29, 2016 to February 07, 2016 as per the Code of Conduct of the under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.